<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>AMR | Nick Brazeau</title><link>https://nicholasbrazeau.com/tags/amr/</link><atom:link href="https://nicholasbrazeau.com/tags/amr/index.xml" rel="self" type="application/rss+xml"/><description>AMR</description><generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© 2023 Nicholas Brazeau</copyright><lastBuildDate>Thu, 19 May 2022 08:00:20 -0700</lastBuildDate><image><url>https://nicholasbrazeau.com/img/headers/tree.jpg</url><title>AMR</title><link>https://nicholasbrazeau.com/tags/amr/</link></image><item><title>AMR in the Hospital</title><link>https://nicholasbrazeau.com/project/sepidapto/</link><pubDate>Thu, 19 May 2022 08:00:20 -0700</pubDate><guid>https://nicholasbrazeau.com/project/sepidapto/</guid><description>&lt;p>In this case study of a patient with &lt;em>Staphylococcus epidermidis&lt;/em> bacteremia receiving prolonged antibiotics that developed Daptomycin resistance, we used whole genome sequencing and bioinformatic analyses to identify a novel mutation. This project demonstrated the utility in using genomic analysis for the identification and survelliance of putative antimicrobial resistant mutations. This project was published as Brazeau &amp;amp; Levinson &lt;em>et al.&lt;/em> 2020 in Evolution, Medicine, and Public Health&lt;sup id="fnref:1">&lt;a href="#fn:1" class="footnote-ref" role="doc-noteref">1&lt;/a>&lt;/sup>.&lt;/p>
&lt;div class="footnotes" role="doc-endnotes">
&lt;hr>
&lt;ol>
&lt;li id="fn:1">
&lt;p>Brazeau NF, Levinson KJ, Schranz A, Moser KA, Hollis I, Iyer P, Chien C, Bowen A, van Duin D, Lachiewicz A, Andermann T, Jones M, Miller M, Juliano JJ, Bartelt LA. Loss of daptomycin susceptibility in clinical Staphylococcus epidermidis infection coincided with variants in WalK. Evol Med Public Health. 2020 Sep 7;2020(1):219-224. doi: 10.1093/emph/eoaa031. PMID: 33214904; PMCID: PMC7658547.&amp;#160;&lt;a href="#fnref:1" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;/ol>
&lt;/div></description></item><item><title>Antimalarial Resistance in Ethiopia</title><link>https://nicholasbrazeau.com/project/ephiamr/</link><pubDate>Thu, 19 May 2022 08:00:20 -0700</pubDate><guid>https://nicholasbrazeau.com/project/ephiamr/</guid><description>&lt;p>Using samples collected as part of antimalarial drug efficacy studies across Ethiopia over multiple years, we demonstrated that &lt;em>P. falciparum&lt;/em> parasites have evidence of persistence through space and time, despite differing profiles of antimalarial resistance. A main focus of this project was capacity building and increased molecular surveillance capacity at the Ethiopian Public Health Institute and was the first project of a lasting collaboration between the EPHI and UNC. This project was published in the American Journal of Tropical Medicine &amp;amp; Hygeine&lt;sup id="fnref:1">&lt;a href="#fn:1" class="footnote-ref" role="doc-noteref">1&lt;/a>&lt;/sup>.&lt;/p>
&lt;div class="footnotes" role="doc-endnotes">
&lt;hr>
&lt;ol>
&lt;li id="fn:1">
&lt;p>Brazeau NF, Assefa A, Mohammed H, Seme H, Tsadik AG, Parr JB, Keeler C, Hathaway NJ, Meshnick SR, Bailey JA, Kassa M, Juliano JJ, Woyessa A. Pooled Deep Sequencing of Drug Resistance Loci from Plasmodium falciparum Parasites across Ethiopia. Am J Trop Med Hyg. 2019 Nov;101(5):1139-1143. doi: 10.4269/ajtmh.19-0142. PMID: 31516103; PMCID: PMC6838589.&amp;#160;&lt;a href="#fnref:1" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;/ol>
&lt;/div></description></item><item><title>Antimalarial Resistance in the DRC</title><link>https://nicholasbrazeau.com/project/veritydrc/</link><pubDate>Thu, 30 Apr 2020 08:00:20 -0700</pubDate><guid>https://nicholasbrazeau.com/project/veritydrc/</guid><description>&lt;p>Using a massively parallel amplicon sequencing barcode approach, we used genomic analyses to demonstrate that the DRC appears to be a &amp;ldquo;mixing pot&amp;rdquo; for &lt;em>P. falciparum&lt;/em> infections across Sub-Saharan Africa. In addition, we identified strong signals of selection to antimalarial drugs in the DRC that likely have driven gene flow patterns across the country. Alongside analytic support, I lead the analyses on detecting selection using adapted extended haplotype heterozygosity approaches. In addition, I led the bioinformatic analysis identifying the variants for the aforementioned barcode used in the study. This barcode has been used extensively by our research group, as well as several domestic and international groups (initial publication: Verity/Aydemir/Brazeau et al. 2020, Nat Comms).&lt;/p></description></item></channel></rss>